Nevro receives FDA approval for Costa Rica manufacturing operations

Nevro Corp. received FDA approval for its new manufacturing facility in Coyol Free Trade Zone, Alajuela, Costa Rica, for production of spinal cord stimulation systems. The company invested approximately $21 million and expects to begin shipping by end of October 2022.

“We are pleased that the FDA has approved our new global manufacturing operations in Costa Rica.”prnewswire.com

• 1 source
• prnewswire.comNevro Announces FDA Approval of Costa Rica Manufacturing OperationsNevro Corp.Oct 4, 2022

Summarized from public sources; check the original articles before acting on it.